Effects of recombinant cholera toxin B subunit (rCTB) on cellular immune responses: Enhancement of delayed-type hypersensitivity following intranasal co-administration of Mycobacterium bovis-BCG with rCTB

Microbiology and Immunology

Volumn 48, Issue 6, 2004, Pages 457-463

  Maeyama, Jun Ichi ^a   Isaka, Masanori ^b   Yasuda, Yoko ^b   Matano, Keiko ^b   Morokuma, Kazunori ^c   Ohkuma, Kunio ^c   Tochikubo, Kunio ^b   Yamamoto, Saburo ^a   Goto, Norihisa ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^c Chemo Sero Therapeutic Research Institute   (Japan)

Author keywords

BCG; Cellular immunity; Cytokine; Mucosal adjuvant; Recombinant cholera toxin B subunit (rCTB)

Indexed keywords

BCG VACCINE; CHOLERA TOXIN B SUBUNIT; GAMMA INTERFERON; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DRUG POTENTIATION; FEMALE; GUINEA PIG; IMMUNOREACTIVITY; IMMUNOSTIMULATION; INTERFERON PRODUCTION; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; SPLEEN CELL; TUBERCULIN TEST;

ANIMALIA; CAVIA; CAVIA PORCELLUS; MYCOBACTERIUM; MYCOBACTERIUM BOVIS BCG; POSIBACTERIA; SUS SCROFA;

EID: 3042718954     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2004.tb03536.x     Document Type: Article

References (32)

1. Biet, F., Kremer, L., Wolowczuk, I., Delacre, M., and Locht, C. 2003. Immune response induced by recombinant Mycobacterium bovis BCG producing the cholera toxin B subunit. Infect. Immun. 71: 2933-2937.
2. Brightbill, H.D., and Modlin, R.L. 2000. Toll-like receptors: molecular mechanisms of the mammalian immune response. Immunology 101: 1-10.
3. Elson, C.O., and Ealding, W. 1984. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 132: 2736-2741.
4. Falero-Diaz, G., Challacombe, S., Banerjee, D., Douce, G., Boyd, A., and Ivanyi, J. 2000. Intranasal vaccination of mice against infection with Mycobacterium tuberculosis. Vaccine 18: 3223-3229.
5. Flick, D.A., and Gifford, G.E. 1984. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J. Immunol. Methods 68: 167-175.
6. Goto, N., Maeyama, J., Yasuda, Y., Isaka, M., Matano, K., Kozuka, S., Taniguchi, T., Miura, Y., Ohkuma, K., and Tochikubo, K. 2000. Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant. Vaccine 18: 2164-2171.
7. Gros, P., Skamene, E., and Forget, A. 1981. Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. J. Immunol. 127: 2417-2421.
8. Hoffmann, J.A., Kafatos, F.C., Janeway, C.A., and Ezekowitz, R.A.B. 2000. Phylogenetic perspectives in innate immunity. Science 284: 1313-1318.
9. Holmgren., J., Lycke, N., and Czerkinsky, C. 1993. Cholera toxin and cholera B subunit as oral mucosal adjuvant and antigen vector systems. Vaccine 11: 1179-1184.
10. Hornquist, E., and Lycke, N. 1993. Cholera toxin adjuvant greatly promotes antigen priming of T cells. Eur. J. Immunol. 23: 2136-2143.
11. Husband, A.J., Beagley, K.W., and McGhee, J.R. 1999. Mucosal cytokines, p. 541-557. In Ogra, P.L., Mestecky, J., Lamm, M.E., Strober, W., Bienenstock, J., and McGhee, J.R. (eds), Mucosal immunology, 2nd ed, Academic Press, San Diego.
12. Huygen, K., Abramowicz, D., Vandenbussche, P., Jacobs, F., Bruyn, J.D., Kentos, A., Drowart, A., Vooren, J.-P.V., and Goldman, M. 1992. Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice. Infect. Immun. 60: 2880-2886.
13. Isaka, M., Yasuda, Y., Kozuka, S., Miura, K., Taniguchi, T., Matano, K., Goto, N., and Tochikubo, K. 1998. Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit. Vaccine 16: 1620-1626.
14. Isaka, M., Yasuda, Y., Kozuka, S., Taniguchi, T., Matano, K., Maeyama, J., Komiya, T., Ohkuma, K., Goto, N., and Tochikubo, K. 2000. Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvant. Vaccine 18: 743-451.
15. Isaka, M., Yasuda, Y., Mizokami, M., Kozuka, S., Taniguchi, T., Matano, K., Maeyama, J., Mizuno, K., Morokuma, K., Ohkuma, K., Goto, N., and Tochikubo, K. 2001. Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant. Vaccine 19: 1460-1466.
16. Lyadova, I.V., Vordermeier, H.M., Eruslanov, E.B., Khaidukov, S.V., Apt, A.S., and Hewinson, R.G. 2001. Intranasal BCG vaccination protects BALB/c mice against virulent Mycobacterium bovis and accelerates production of IFN-γ in their lungs. Clin. Exp. Immunol. 126: 274-279.
17. Lycke, N., and Holmgren, J. 1986. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 59: 301-308.
18. Maeyama, J., Isaka, M., Yasuda, Y., Matano, K., Kozuka, S., Taniguchi, T., Ohkuma, K., Tochikubo, K., and Goto, N. 2001. Cytokine responses to recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant. Microbiol. Immunol. 45: 111-117.
19. Maeyama, J., Isaka, M., Yasuda, Y., Matano, K., Kozuka, S., Taniguchi, T., Ohkuma, K., Tochikubo, K., and Goto, N. 2002. Effects of recombinant cholera toxin B subunit on IL-1β production by macrophages in vitro. Microbiol. Immunol. 46: 593-599.
20. McSorley, S.J., Rask, C., Pichot, R., Julia, V., Cerkinsky, C., and Glaichenhaus, N. 1998. Selective tolerization of Th1-like cells after nasal administration of a cholera toxoid-LACK conjugate. Eur. J. Immunnol. 28: 424-432.
21. Okahashi, N., Yamamoto, M., Kiyono, H., and McGhee, J.R. 1996. Mucosal immunity in IL-4 knock out mouse. Infect. Immun. 64: 1516-1525.
22. Ramsey, A.J., and Kohonen, C.M. 1993. Interleukin-5 expressed by a recombinant virus vector enhances specific mucosal IgA responses in vivo. Eur. J. Immunol. 23: 3141-3145.
23. Tochikubo, K., Isaka, M., Yasuda, Y., Kozuka, S., Matano, K., Miura, Y., and Taniguchi, T. 1998. Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin. Vaccine 16: 150-155.
24. Tominaga, A., and Takaki, S. 1991. Transgenic mice expressing a B cell growth and differentiation factor (interleukin-5) develop eosinophilia and autoantibody production. J. Exp. Med. 173: 429-437.
25. Trinchieri, G. 1994. Interleukin-12. Blood 84: 4008-4027.
26. Vajdy, M., Kosco-Vilbois, M.H., Kopf, M., Kohler, G., and Lycke, N. 1995. Impaired mucosal immune responses in interleukin 4-targeted mice. J. Exp. Med. 181: 41-53.
27. Wakeham, J., Wang, J., and Xing, Z. 2000. Genetically determined disparate innate and adaptive cell-mediated immune responses to pulmonary Mycobacterium bovis BCG infection in C57BL/6 and BALB/c mice. Infect. Immun. 68: 6946-6953.
28. Wiedermann, U., Jahn-Schmid, B., Lindblad, M., Rask, C., Holmgren, J., Kraft, D., and Ebner, C. 1999. Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy. Int. Immunol. 11: 1131-1138.
29. Xu, A.J., Kiyono, H., Jackson, R.J., Staats, H.F., Fujihashi, K., Burrows, P.D., Elson, C.O., Pillai, S., and McGhee, J.R. 1993. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosal associated tissues. J. Exp. Med. 178: 1309-1320.
30. Xu, A.J., Jackson, R.J., Fujihashi, K., Kiyono, H., Staats, H.F., and McGhee, J.R. 1994. Helper Th1 and Th2 responses following mucosal or systemic immunization with cholera toxin. Vaccine 12: 903-911.
31. Yasuda, Y., Matano, K., Asai, T., and Tochikubo, K. 1998. Affinity purification of recombinant cholera toxin B subunit oligomer expressed in Bacillus brevis for potential human use as a mucosal adjuvant. FEMS Immunol. Med. Microbiol. 20: 311-318.
32. Yoshida, A., Koide, Y., Uchijima, M., and Yoshida, T.O. 1995. Dissection of strain difference in acquired protective immunity against Mycobacterium bovis Calmette-Guérin Bacillus (BCG). J. Immunol. 155: 2057-2066.